Posted: December 3, 2009

French Research Institute Uses E-WorkBook Suite to Accelerate Analysis of Nanoparticles

(Nanowerk News) IDBS, the leading worldwide provider of research data management and analytics solutions to R&D organizations, today announced that L'Institut de Biologie et Chimie des Proteines (IBCP), a principal research institute based in Lyon, France, has selected E-WorkBook Suite to manage its research data and knowledge in developing nanoparticles for the treatment of viral infections.
Partnering with leading French and EU research organizations and universities, IBCP is advancing research into the creation of vaccines using nanoparticles made of polylactic acid (PLA), in sizes ranging from 150nm to 400nm, which can emulate the actions of antigens and create a new generation of targeted therapeutics. The biological application of nanoparticles is an area of nanotechnology that is rapidly developing, and it raises new possibilities in the diagnosis and treatment of HIV, Anthrax and FIV (Feline Immunodeficiency Virus).
By using all aspects of E-WorkBook, scientists at IBCP can benefit from a flexible framework to capture, analyze, and manage their experimental data in an efficient and compliant way. The solution's extensive searching and reporting capabilities will accelerate their pace of research, and maximize the quality and re-use of their data. IBCP is provided with an application that will streamline workflow, accelerate discovery research, and improve productivity, while ensuring quality control for standard operating procedures (SOPs) and protecting Intellectual Property (IP).
"I was impressed with the quality of results E-WorkBook produced for our colleagues from CEA (Fontenay-aux-Roses, France), and therefore it was the natural choice for our laboratory," said Professor Bernard Verrier, Senior Scientist at IBCP. "Using E-WorkBook we will have a clearer picture of the research going on in our lab, improving the quality and quantity of reports and scientific papers, and enabling better interpretation of results. Using this solution to manage our data will save us several months of work, preventing duplication of experiments and ensuring that new users to the system have a comprehensive view of all data."
"Nanotechnology is at the leading-edge of scientific research that has the potential to push technological boundaries," said Neil Kipling, founder and CEO of IDBS. "IBCP recognizes the power and flexibility of the E-WorkBook Suite and how it can be applied to further their pioneering work, which could represent a breakthrough in vaccinations for potentially fatal diseases. This relationship reaffirms IDBS' position at the forefront of scientific endeavor."
About IDBS
IDBS is a unique, global supplier of innovative data management and analytics solutions which increase efficiency, reduce costs, and improve the business and scientific productivity of R&D organizations worldwide.
Organizations such as Pfizer, GSK, Celera, MedImmune, Dana-Farber, and Roche employ IDBS solutions as an integral part of their strategy to address the increasing pressures placed upon them by the need for the secure and compliant capture, integration, and analysis of complex research data. IDBS is clearly differentiated from other software providers by its unique combination of deep domain knowledge and its ability to rapidly provide integrated business process and robust data analytics solutions along the entire R&D value chain. IDBS solutions secure organizations' valuable R&D data assets and enable rapid decision-making through effective integration and analysis. They also support the protection of Intellectual Property (IP) and the requirements for data quality demanded under Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) standards.
Source: IDBS (press release)
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
These articles might interest you as well: